Sutro Biopharma (STRO) Interest & Investment Income (2017 - 2025)
Sutro Biopharma (STRO) reported Interest & Investment Income of -$782000.0 for Q4 2025, up 90.27% on a YoY basis from -$410987.1 in Q4 2024, and down 6.11% sequentially from -$737000.0 in Q3 2025.
Sutro Biopharma (STRO) Interest & Investment Income (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Interest & Investment Income data on file, last reported at -$782000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income rose 90.27% year-over-year to -$782000.0; the trailing twelve-month figure through Dec 2025 stood at $4.2 million (down 58.75% YoY), and the FY2025 full-year result was -$3.9 million, down 120.68% from the prior year.
- Interest & Investment Income eased to -$782000.0 in Q4 2025, from -$737000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $22.2 million in Q3 2024 to a low of -$8.0 million in Q4 2024.
- A 5-year average of $802500.0 and a median of $102500.0 in 2021 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 7706.25% in 2022 and slumped 2674.14% in 2023, its largest moves.
- Tracing STRO's Interest & Investment Income over 5 years: stood at $96000.0 in 2021, then soared by 7706.25% to $7.5 million in 2022, then slumped by 133.89% to -$2.5 million in 2023, then tumbled by 216.54% to -$8.0 million in 2024, then surged by 90.27% to -$782000.0 in 2025.
- Business Quant data shows STRO's Interest & Investment Income at -$782000.0 in Q4 2025, -$737000.0 in Q3 2025, and $2.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | -782,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -782,000.00 |
| Sep 30, 2025 | -737,000.00 |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | -8.04 Mn |
| Sep 30, 2024 | 22.17 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Mar 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Sep 30, 2023 | 4.55 Mn |
| Jun 30, 2023 | -2.92 Mn |
| Mar 31, 2023 | -2.99 Mn |
| Dec 31, 2022 | 7.49 Mn |
| Sep 30, 2022 | -2.79 Mn |
| Jun 30, 2022 | 197,000.00 |
| Mar 31, 2022 | 116,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 109,000.00 |
| Jun 30, 2021 | 175,000.00 |
| Mar 31, 2021 | 197,000.00 |